Yoh S, Isayama T, Yoshitake K, Fujihara A, Kanamiya T, Ogata K, Inoue K, Maehara Y, Baba H
Dept. of Orthopedic Surgery, School of Medicine, Fukuoka University.
Gan To Kagaku Ryoho. 1994 Sep;21(13):2315-9.
We treated three patients with osteosarcoma in extremity with intra-arterial combination chemotherapy using a regimen selected by succinate dehydrogenase inhibition chemosensitivity test, and used caffeine to enhance its effect. In two patients with osteosarcoma in distal diametaphysis of the radius and extraskeletal osteosarcoma in sole of the foot, the effect of intra-arterial combination chemotherapy was increased and followed by the functional limb salvage procedure. But in one patient with osteosarcoma in the proximal tibia, the effect of pre-operative intra-arterial combination chemotherapy could not be increased, so amputation was required. He was changed to a post-operative intra-venous combination chemotherapy regimen selected by chemosensitivity test of the surgical material. All patients have been continuously disease-free at five to twelve months after surgery.
我们对3例肢体骨肉瘤患者采用经琥珀酸脱氢酶抑制化学敏感性试验选择的方案进行动脉内联合化疗,并使用咖啡因增强其效果。在2例桡骨远端骨干骨肉瘤和足底骨外骨肉瘤患者中,动脉内联合化疗的效果增强,随后进行了保肢功能手术。但在1例胫骨近端骨肉瘤患者中,术前动脉内联合化疗的效果未能增强,因此需要截肢。术后将其改为根据手术材料化学敏感性试验选择的静脉内联合化疗方案。所有患者术后5至12个月均持续无病。